In the U.S., about 6% of adults currently use GLP-1s, and 12% have used them in the past (2024 data) (Mozafariun 2025)
Trulicity is prescribed as a treatment for diabetes and for off-label weight-loss purposes
Lorenz M, Evers A, Wagner M (2013) Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
Furthermore, certain medications, particularly antidepressants and hormone therapies, can also trigger night sweats, making it essential for individuals to discuss their symptoms with healthcare providers to identify potential causes and appropriate treatments
According to research published in Diabetes Care, microdosing offers a tailored solution to maximize therapeutic benefit, minimize adverse effects, and address medication availability concerns
- Viola F